Imatinib Mesylate in Treating Patients With Gliomas

NCT00039364 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

NETWORK

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: imatinib mesylate

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC